Startups
Mogrify

Mogrify

https://mogrify.co.uk

Mogrify® will transform the development of ex vivo cell therapies and pioneer a new class of in vivo reprogramming therapies.

Summary

Seedtable Score
  • 31
Locations
Company Size
  • 101 to 250 employees
Last Stage Round
  • Series A
Industry

Total funding Amount

$38M

Fundraising History

  • Oct 02 '23 Series A
    $10M
  • May 01 '21 Series A
    $17M
  • Oct 01 '19 Series A
    $16M
  • Feb 01 '19 Seed
    $3.7M

Investors

  • Astellas Venture Management
    Series A
  • Ahren Innovation Capital
    Series A
  • Parkwalk Advisors
    Series A